Researchers at the University of California, Berkeley, have developed a new method for the dual-site migration of molecules using boracycle rearrangement [1].

This breakthrough allows for more precise and controlled movement of molecules within complex systems. Such control is essential for advancing the efficiency of molecular transport, which serves as the foundation for developing next-generation chemical synthesis and targeted delivery mechanisms.

The study, published Nov. 2, 2026 [2], details how the boracycle rearrangement provides a robust and efficient pathway for this migration [1]. By utilizing this specific chemical process, the team can direct molecules to move between two distinct sites with a level of accuracy previously difficult to achieve.

"This new method offers a significant advance in the field of molecular transport," said Dr. Emily Carter, the lead author of the study [1].

The research team said that the boracycle rearrangement is a key driver in creating this reliable pathway for dual-site migration [1]. This mechanism enables the manipulation of molecular structures in ways that could reduce waste and increase the speed of chemical reactions.

Dr. Carter said the technology has broad applications in areas such as drug delivery and materials science [1]. In drug delivery, for example, the ability to precisely migrate molecules could allow for more effective targeting of diseased cells while leaving healthy tissue untouched.

The findings were shared in the journal Nature [1]. The Berkeley team focused on the stability and reproducibility of the rearrangement to ensure the method could be scaled, or adapted, for different types of molecular structures [1].

“"This new method offers a significant advance in the field of molecular transport,"”

The ability to control the movement of molecules at a dual-site level represents a shift toward more programmable chemistry. By mastering boracycle rearrangement, scientists can potentially design synthetic pathways that mimic biological precision, reducing the trial-and-error process in pharmaceutical development and the creation of advanced polymers.